CNBC: Bill George: Bresch Should Commit to No Further Price Increases

Bill George

CNBC Contributor Bill George, former CEO of Medtronic, and Darnisha Harrison, Ennaid Therapeutics CEO, discuss the controversy surrounding Mylan’s pricing of the EpiPen.


This content was originally posted on CNBC on 8/25/16.

Leave a Reply

Your email address will not be published. Required fields are marked *